NEGpre-221 pre-222pre-221/222 NEG DMSO 100 nM Fulvestrant for 72h Figure S1. Cell morphology of MCF7 cells after treatment with fulvestrant, with or without.
Figure S1: (A) Table shows number of genes that passed Welchs t-test at different q-values (FDR corrected p-values) and Fold Change cut-offs. (B) Immune.
Figure S1. In absence of Rvb1, treatment with various DNA damaging agents results in increased phosphoH2AX. HeLa cells were transfected with indicated.
Figure S1 – The ammount of depleted glutathione is similar to the ammount of extracellular glutathione after staurosporine (STS) treament. The graph shows.
Figure S1: Mathematical model of CD14 signaling pathway.
Figure S1. RNA-seq results for caveolin-1 (Cav1). Upper panel: UCSC genome browser view. Lower panel: quantification o f Cav1 expression based on RNA-seq.
PubMed abstracts (108 genes)
Figure S1. (A-H) Current/voltage curves in KCl. (I) The conductance at reversal potential with cytosolic [K + ] held at 250 mM and lumenal [K + ] is varied.
WT control
am400520d_si_001
Figure S1. Alignment of sequences from the 5′-end to the Sm binding site of reported genomic sequences (9-15) for HSUR 1. MicroRNA binding sites are.
98 97
![Figure S1. (A-H) Current/voltage curves in KCl. (I) The conductance at reversal potential with cytosolic [K + ] held at 250 mM and lumenal [K + ] is varied.](https://static.fdocuments.net/doc/330x215/56649e9e5503460f94b9f802/figure-s1-a-h-currentvoltage-curves-in-kcl-i-the-conductance-at-reversal.jpg)
